Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer-Reference-Cited by-同舟云学术

Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer

Published:2018-01-25 Issue:5 Volume:175 Page:743-762
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Tankiewicz-Kwedlo Anna¹^ORCID,Hermanowicz Justyna Magdalena²³,Domaniewski Tomasz¹,Pawlak Krystyna¹,Rusak Małgorzata⁴,Pryczynicz Anna⁵,Surazynski Arkadiusz⁶,Kaminski Tomasz²,Kazberuk Adam⁶,Pawlak Dariusz²

Affiliation:

1. Department of Monitored Pharmacotherapy; Medical University of Bialystok; Bialystok Poland

2. Department of Pharmacodynamics; Medical University of Bialystok; Bialystok Poland

3. Department of Clinical Pharmacy; Medical University of Bialystok; Bialystok Poland

4. Department of Hematological Diagnostics; Medical University of Bialystok; Bialystok Poland

5. Department of Pathomorphology; Medical University of Bialystok; Bialystok Poland

6. Department of Medicinal Chemistry; Medical University of Bialystok; Bialystok Poland

Funder

Narodowe Centrum Nauki

Leading National Science Centre in Bialystok

Uniwersytet Medyczny w Bialymstoku

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.14099/fullpdf

Reference54 articles.

1. Erythropoietin and erythropoietin receptor expression in human cancer;Acs;Cancer Res,2001

2. Ibrutinib and novel Btk inhibitors in clinical development;Akinleye;J Hematol Oncol,2013

3. The BTK inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity;Akker;Biol Chem,2004

4. The concise guide to PHARMACOLOGY 2017/18: catalytic receptors;Alexander;Br J Pharmacol,2017a

5. The concise guide to PHARMACOLOGY 2017/18: enzymes;Alexander;Br J Pharmacol,2017b

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based classification models for non-covalent Bruton’s tyrosine kinase inhibitors: predictive ability and interpretability;Molecular Diversity;2023-07-21

2. Machine Learning-Based Classification Models for Non-Covalent Bruton's Tyrosine Kinase Inhibitors: Predictive Ability and Interpretability;2023-05-11

3. Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials;Molecules;2023-03-06

4. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer;Aging;2022-11-28

5. Recombinant human erythropoietin accelerated the proliferation of non‐small cell lung cancer cell lines and reduced the expression of VEGF, HIF‐1α, and PD‐L1 under a simulated hypoxic environment in vitro;Chronic Diseases and Translational Medicine;2022-03-31